Surgical robotics gains momentum with AI chips and sensors

Surgical robotics is moving deeper into mainstream medical care as hospitals adopt automated systems designed to support more precise and less invasive procedures. The industry is projected to reach a valuation of USD 38.27 billion by 2035, reflecting rising demand for platforms that help surgeons perform complex tasks with greater accuracy.

The United States leads adoption, supported by a large installed base of robotic systems and major medical robotics companies. Platforms such as Intuitive Surgical’s da Vinci system and Medtronic’s Hugo system are cited alongside companies including Stryker and Zimmer Biomet as part of a growing ecosystem for robot-assisted surgery.

New systems are adding AI chips and precision sensors that deliver real-time feedback during procedures. These tools are described as improving surgical decision-making, reducing tissue damage and blood loss, and enabling smaller incisions that can lead to shorter hospital stays and faster recovery.

Hospitals are also weighing economic benefits. Greater efficiency can allow facilities to perform more procedures while reducing complications, readmissions and extended care needs, making robotic surgery both a clinical and operational investment.